Mentana DX SRL
Mentana DX reported total assets of 229,998 € at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Jul 2026).
The score of Mentana DX shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Equity -23 % Total assets -22 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Mentana DX's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Jul 2026
- Year ended 31 Dec 2024filed on 11 Jul 2025
- Year ended 31 Dec 2023filed on 05 Aug 2024
Mentana DX's financial analysis
- Solvency99.4%sector median: 60.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Mentana DX
Mentana DX's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0786.290.908
- VAT number
- BE0786290908
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SRL
- Incorporated
- 17 May 2022
- Registered office
- 9940 Evergem
- Latest accounts
- 2025 · filed on 30 Jul 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
Mentana DX (SRL) has been based in Evergem since 2022, active in: research and experimental development on biotechnology. For 2025, it reports a net loss of 31,505 € and equity of 228,548 €; its revenue is not published. Its solvency stands at 99.4%, above the median of its sector (60.4%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Mentana DX
Companies in the same business, of comparable size and area, outside its group.
- Grand Medical (Europe) Research and experimental development on natural sciences and engineering Niel · balance sheet 135,260 €
- Ergotrics Research and experimental development on natural sciences and engineering Turnhout · balance sheet 376,384 €
- Elkedonia Belgium Research and experimental development on natural sciences and engineering Charleroi · balance sheet 228,425 €
- Hemastatx Research and experimental development on natural sciences and engineering Charleroi · balance sheet 200,755 €
- M3bio Consulting Research and experimental development on natural sciences and engineering Beveren-Kruibeke-Zwijndrecht · balance sheet 229,772 €
- Ferrons Research and experimental development on natural sciences and engineering Ternat · balance sheet 231,903 €
- Flindr Labs Manufacture of pharmaceutical preparations Ghent · balance sheet 262,929 €
- Groovy.Bio Manufacture of pharmaceutical preparations Evergem · balance sheet 744,069 €
Frequently asked questions about Mentana DX
What is the revenue of Mentana DX?
Mentana DX files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Mentana DX?
In Belgium, the VAT number is the company number prefixed with BE: BE0786290908 for Mentana DX, if the company is VAT-registered. Its company number (CBE) is 0786.290.908.
Where is the registered office of Mentana DX?
According to the CBE register, the registered office of Mentana DX is in 9940 Evergem.
What is the equity of Mentana DX?
At the close of the 2025 financial year, the equity of Mentana DX amounts to 228,548 €, a solvency of 99.4% of total assets.
Who manages Mentana DX?
The register lists 2 active mandates at Mentana DX. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Mentana DX
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →